Transforming growth factor beta (TGFβ) and keloid disease

International Journal of Surgery

Volumn 5, Issue 4, 2007, Pages 278-285

  Jagadeesan, Jagajeevan ^a   Bayat, Ardeshir ^b  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Fibrosis; Keloid disease; Skin scarring; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

FIBROBLAST; FIBROSIS; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; HUMAN; KELOID; MORPHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; WOUND HEALING;

COLLAGEN; HUMANS; KELOID; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 34447625195     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2006.04.007     Document Type: Review

References (62)

1. Tredget E.E., Nedelec B., Scott P.G., and Ghahary A. Hypertrophic scars, keloids and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77 (1997) 701-730
2. Bayat A., McGrouther D.A., and Ferguson M.W.J. Medicine, science and future series: skin scarring. Br Med J 326 (2003) 88-92
3. Bayat A., Arscott G., Ollier W.E.R., Ferguson M.W.J., and McGrouther D.A. Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population. Br J Plast Surg 57 2 (2004) 122-133
4. Bayat A., Arscott G., Ollier W.E.R., McGrouther D.A., and Ferguson M.W.J. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg 58 1 (2005) 28-37
5. Urioste S.S., Arndt K.A., and Dover J.S. Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg 18 (1999) 159-171
6. Khan S. The pathology of keloid scars. Surgery 71 (1983) 821-825
7. Kischer C.W., and Brody G.S. Structure of collagen nodule from hypertrophic scars and keloids. Scanning Microsc 3 (1981) 371-376
8. Lee K.S., Song J.Y., and Suh M.H. Collagen mRNA expression detected in situ hybridisation in keloid tissue. J Dermatol Sci 2 (1991) 316-323
9. Thomas D.W., Hopkinson I., Harding K.G., and Shepherd P. The pathogenesis of hypertrophic/keloid scarring. Int J Oral Maxillofac Surg 23 (1994) 232-236
10. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 (1999) 738-746
11. Daian T., Ohtsuru A., Rogounovitch T., Ishihara H., Hirano A., Akiyama-Uchida Y., et al. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol 120 6 (2003) 956-962
12. Niessen F.B., Spauwen P.H., Schalkwijk J., and Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104 (1999) 1435-1458
13. Tuan T.L., and Nichter L.S. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4 (1998) 19-24
14. Border W.A., and Nobel N.A. Transforming growth factor β in tissue fibrosis. N Engl J Med 331 (1994) 1286-1292
15. Border W.A., and Noble N.A. Targeting TGF-beta for treatment of disease. Nat Med 1 10 (1995) 1000-1001
16. Chin D., Boyle G.M., Parsons P.G., and Coman W.B. What is transforming growth factor beta (TGFβ)?. Br J Plast Surg 57 (2004) 215-221
17. Goumans M.J., and Mummery C. Functional analysis of the TGFβ receptor. Smad pathway through gene ablation mice. Int J Dev Biol 44 (2000) 253-265
18. Sporn M.B., Roberts A.B., Wakefield Lar M., and Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105 (1987) 1039-1045
19. Varga J., Rosenbloom J., and Jimenez S.A. Transforming growth factor β causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247 (1987) 597-604
20. Khalil N. Transforming growth factor β: from latent to active. Microbes Infect 1 (1999) 1255-1263
21. Derynck R., Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316 (1985) 701-705
22. Flanders K.C., Burmester J.K., and Sporn M.B. Medical applications of transforming growth factor-β. Clin Med Res 1 (2003) 13-20
23. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., and Sporn M.B. Transforming growth factor beta in human platelets; identification of a major storage site, purification and characterization. J Biol Chem 258 (1983) 7155-7160
24. Assoian R.K., and Sporn M.B. Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle. Cell 102 (1986) 1217-1223
25. Shah M., Foreman D.M., and Ferguson M.W.J. Neutralisation of TGFβ1 and TGFβ2 or exogenous addition of TGFβ3 to cutaneous rat wounds reduces scarring. J Cell Sci 108 (1995) 985-1002
26. Roberts A.B. Transforming growth factor-β: activity and efficacy in animal models of wound healing. Wound Repair Regener 3 (1995) 408-418
27. Bayat A., Bock O., Mrowietz U., Ollier W.E.R., and Ferguson M.W.J. Genetic susceptibility to keloid disease and transforming growth factorβ2 polymorphisms. Br J Plast Surg 55 (2002) 283-286
28. Bissell D.M., Roulot D., and George J. Transforming growth factor β and the liver. Hepatology 34 (2001) 859-867
29. Liu B., and Connolly M.K. The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg 17 (1998) 3-11
30. Derynck R., Gelbart W.M., Harland R.M., Heldin C.H., Kern S.E., Massagué J., et al. Nomenclature: vertebrate mediators of TGF beta family signals. Cell 87 (1996) 173
31. Derynck R., and Zhang Y. Intracellular signalling: the mad way to do it. Curr Biol 6 (1996) 1226-1229
32. Derynck R., and Zhang Y. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
33. Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
34. Kim C.W., Suh S., Sung S.H., Lee I.K., and Lee K.S. A Transcriptional factor decoy against AP-1 suppresses TGFβ1 induced type I collagen gene expression in cultured keloid fibroblasts. J Dermatol Sci 37 (2005) 49-51
35. Rifkin D.B., Mazzieri R., Munger J.S., Noguera I., and Sung J. Proteolytic control of Growth factor availability. APMIS 107 (1999) 80-85
36. Leask A., and Abraham D.J. TGF-beta signalling and the fibrotic response. FASEB J 18 7 (2004) 816-827
37. Verrecchia F., and Mauviel A. Transforming growth factor-beta signalling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118 2 (2002) 211-215
38. Kamamoto F., Paggiaro A.O., Rodas A., Herson M.R., Mathor M.B., and Ferreira M.C. A wound contraction experimental model for studying keloids and wound healing modulators. Artif Organs 27 (2003) 701-705
39. Brown R.L., Ormsby I., Doetschman T.C., and Greenhalgh D.G. Wound healing in transforming growth factorβ1 deficient mouse. Wound Rep Reg 3 (1995) 25-36
40. Streuli C.H., Schmidhauser C., Kobrin M., Bissell M.J., and Derynck R. Extracellular matrix regulates expression of TGFβ1 gene. J Cell Bio 120 (1993) 253-260
41. Shah M., Foreman D.M., and Ferguson M.W. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339 (1992) 213-214
42. Wang X., Smith P., Pu L.L., Kim Y.J., Ko F., and Robson M.C. Exogenous transforming growth factor beta (2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 87 2 (1999) 194-200
43. Lanning D., Diegelmann R.F., Yager D.R., Wallace M.L., Bagwell C.E., and Haynes J.H. Myofibroblast induction with transforming growth factor-β1 and -β3 in cutaneous fetal excisional wounds. J Pediatr Surg 35 2 (2000) 183-188
44. Peltonen J., Hsiao L.L., Jaakkola S., Sollberg S., Aumailley M., Timpl R., et al. Activation of collagen gene expression in keloids: Co-Localisation of type I and VI collagen and transforming growth factorβ1 mRNA. J Invest Dermatol 97 (1991) 240-248
45. Babu M., Diegelmann R., and Oliver N. Keloid fibroblasts exhibit an altered response to TGF-beta. J Invest Dermatol 99 (1992) 650-655
46. Bettinger D.A., Yager D.R., and Diegelmann R.F. The effect of TGFβ of keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 98 5 (1996) 827-833
47. Suzawa H., Kikuchi S., Arai N., and Koda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 60 2 (1992) 91-96
48. Younai S., Nichter L.S., Wellisz T., Reinisch J., Nimni M.E., and Tuan T.L. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 33 2 (1994) 148-151
49. Fujiwara M., Muragaki Y., and Ooshima A. Keloid derived fibroblasts showed increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 153 (2005) 295-300
50. Polo M., Smith P.D., Kim Y.J., Wang X., Ko F., and Robson M.C. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 43 (1999) 185-190
51. Smith P., Mosiello G., Deluca L., Ko F., Maggi S., and Robson M.C. TGF-beta2 activates proliferative scar fibroblasts. J Surg Res 82 (1999) 319-323
52. Lee T.Y., Chin G.S., Kim W.J., Chau D., Gittes G.K., and Longaker M.T. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43 2 (1999) 179-184
53. Chipev C.C., Simman R., Hatch G., Katz A.E., Siegel D.M., and Simon M. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ 7 2 (2000) 166-176
54. Bock O., Yu H., Zitron S., Bayat A., Ferguson M.W., and Mrowietz U. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol 85 (2005) 216-220
55. Chin G.S., Liu W., Peled Z., Lee T.Y., Steinbrech D.S., Hsu M., et al. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108 (2001) 423-429
56. Phan T.T., Lim I.J., Aalami O., Lorget F., Khoo A., Tan E.K., et al. Smad 3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol 207 (2005) 232-242
57. Yu H., Bock O., Bayat A., Ferguson M.W., and Mrowietz U. Decreased expression of inhibitory SMAD 6 and SMAD 7 in keloid scarring. J Plast Reconstr Aesthet Surg 59 (2006) 221-229
58. Bayat A., Bock O., Mrowietz U., Ollier W.E.R., and Ferguson M.W.J. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor β1 common polymorphisms and plasma levels. Plast Reconstr Surg 111 (2003) 535-543
59. Bayat A., Walker J.M., Bock O., Mrowietz U., Ollier W.E.R., and Ferguson M.W.J. Genetic susceptibility of keloid disease: Mutation screening of TGFβ3 gene. Br J Plast Surg 58 (2005) 914-921
60. Bayat A., Bock O., Mrowietz U., Ollier W.E.R., and Ferguson M.W.J. Genetic susceptibility to keloid disease: transforming growth factor β receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 13 (2004) 120-124
61. Uitto J., and Kouba D. Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci 24 (2000) S60-S69
62. Parrelli J.M., Meisler N., and Cutroneo K.R. Abrogation of the fibrotic effect of transforming growth factor β in dermal wound healing. Wound Rep Reg 5 (1997) 136-140